Skip to main content
Erschienen in: Documenta Ophthalmologica 1/2015

Open Access 01.08.2015 | Original Research Article

Electrophysiological function of the retina and optic nerve in patients with atrial fibrillation

verfasst von: Michal Post, Wojciech Goslawski, Monika Modrzejewska, Maciej Wielusinski, Jaroslaw Kazmierczak, Wojciech Lubinski

Erschienen in: Documenta Ophthalmologica | Ausgabe 1/2015

Abstract

Purpose

To evaluate the effects of atrial fibrillation (AF) and ablation procedures on electrophysiological function in the retina and optic nerve.

Methods

Thirty two eyes of 17 patients with AF were analyzed. The full-field electroretinogram (ERG), pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) were performed. The results were compared to age-matched healthy controls (n = 30). In 12 eyes, electrophysiological tests were performed before and 3 months after ablation treatment.

Results

Statistically significant differences between AF patients and healthy controls were detected. In the full-field ERG, a reduction in the oscillatory potentials wave index (OPs WI; p = 0.012) and scotopic (0 dB) a-wave amplitude (p = 0.009) was observed. The amplitude of b-waves, scotopic (24 dB; p = 0.011), photopic single flash (p = 0.008) and photopic flicker (p = 0.009), was decreased. The photopic flicker b-wave peak time was increased (p = 0.005). Other parameters of ERG/PERG/PVEP did not differ significantly from controls. After the ablation procedure, the only statistically significant change was an increase in the OPs WI (p = 0.002).

Conclusions

In the analyzed series of AF patients, retinal dysfunction was detected in the ERG test. The AF ablation may improve the retinal function as indicated by an increase in the OPs WI. The OPs WI has a potential value in the estimation of the effectiveness of AF ablation.

Introduction

Atrial fibrillation (AF) is the most common cardiac arrhythmia affecting 0.4–1 % of the population [1]. Approximately 2.2 million individuals in the USA and 4.5 million in the European Union have AF [1], and the number of patients is likely to increase during the next 50 years, in consequence of the growing proportion of elderly individuals [2, 3]. Rate or rhythm controls are the two possible methods to manage AF. The ablation procedure is nowadays a widely acceptable method of rhythm control. The essence of the AF ablation is to make an electrical isolation between the pulmonary veins (which are the most common place of AF triggers) and the cardiac left atrium [4].
In AF patients, cardiac output decreases by 20–30 % [4], causing reduction in the organs’ blood supply and generating the ischemia of the central nervous system (CNS). Therefore, the optimal effect of AF treatment should be taken into account of not only heart function, but also in case of the CNS. There are many appliances to assess improved blood flow after AF ablation at different levels: carotid ultrasonography [5], fluorescent microspheres in retinal circulation [6] and cerebral computed/radionuclide angiography [7]. However, electrophysiological tests directly measure the function of the retina and optic nerve. The inner retina has a similar oxygen consumption rate as the brain (2–5 ml O2/100 g min) [8] and similar oxygen tension in dark adaptation as the myocardium [9, 10]. However, the outer retina is more sensitive to hypoxemia. This is due to the fact that photoreceptors’ (especially rods’) high oxygen consumption varies between 3.9 and 5.1 ml O2/100 g min in dark adaptation [1113] and is reduced by 30–70 % in light adaptation [11, 12, 14, 15]. Photoreceptors are supplied mostly from choroidal circulation, which has no autoregulation [6, 16, 17]. Consequently, the outer retina is susceptible to ischemia due to systemic hypoxia. Therefore, the outer retinal dysfunction occurs, when blood oxygen tension has value of <70–80 mmHg, while in the inner retina (supplied by the central retinal artery) the first signs begin below pO2 < 40 mmHg [18, 19]. All of these data insinuate that in patients with AF dysfunction of rods (in scotopic conditions) will occur in the first place.
The present study is the first to evaluate the influence of the cardiac arrhythmia (AF) and its treatment (ablation) on the function of the retina/optic nerve/CNS.

Methods

Thirty-two eyes of 17 patients with AF were analyzed. They were randomly selected from the group of patients who underwent the AF ablation in the Department of Cardiology PMU. The ocular inclusion criteria were the best-corrected distance visual acuity (VA) > 0.5 (Snellen chart) and normal results of routine ophthalmological examination. Patients with diseases (e.g. diabetes mellitus, heart failure), with hemodynamically significant internal carotid artery stenosis (>70 %) or taking drugs (e.g. propranolol) with known influence on the function of the retina and optic nerve were excluded. Patients with treated hypertension (RR < 140/90) were enrolled.
The electrophysiological tests mentioned below were performed in all patients: full-field electroretinogram (ERG), pattern electroretinogram (PERG) and pattern visual evoked potentials (PVEP). All results were compared with age-matched healthy controls (n = 30), and parameters of the tests were as follows.

Full-field electroretinogram (ERG)

Recordings of the flash ERG, scotopic oscillatory potentials were performed using the UTAS-E 2000 system (LKC Technologies, Inc.). The ERG test parameters were performed in accordance with ISCEV standard [20, 21] with some reduction in flash strength. The patients’ pupils were dilated with 10 % neosynephrine and 1 % tropicamide eye drops. The ERG responses were then recorded from the anesthetized cornea (0.5 % proxymetacaine) using a Burian–Allen bipolar contact lens electrode; a gold ground electrode was placed on the ear. Interelectrode impedance was maintained as <5 kΩ. A 30-min dark adaptation (20 min according to the ISCEV) preceded the rod and the mixed cone-rod recordings; a 10-min period of light adaptation preceded the photopic cone and flicker recordings. The rod ERG recordings were obtained with single white flashes (Grass Flash xenon lamp, luminance 1.58 cd s/m2, ISCEV: 0.025 scotopic cd s/m2, equivalent to 0.01 photopic cd s/m2) attenuated by a 24-dB neutral filter. The mixed rod-cone ERGs (maximal response) were elicited with flashes of white light (luminance: 1.58 cd s/m2, ISCEV: 3 cd s/m2). The cone ERGs were elicited with white flashes of the same intensity. The luminance of the background was 30 cd/m2. In the flicker recordings, the frequency of stimulation was 30 Hz (the same conditions of adaptation) and ten sweeps were averaged. The bandpass filter resulted within 0.3–500 Hz in all recordings. The oscillatory potentials in the scotopic state were obtained with white flashes (luminance: 1.58 cd s/m2, ISCEV: 3 cd s/m2). The high-pass filter was 75 Hz, and the low-pass filter was 500 Hz. Overall wave index of OPs amplitudes (O1 + O2 + O3 + O4) was measured. The artifact reject threshold was off in all flash ERG recordings, and the notch filters were off.

Pattern electroretinogram (PERG)

The PERG was recorded with the RetiPort System (Roland Consult Instr.) using a protocol implemented in the original software of the system. Monocular stimulation was used, together with appropriate refractive error correction in relation to the eye-screen distance. Examination was interrupted when frequent blinking or fixation losses were observed (patient was monitored with a TV camera). The patients’ pupils were not dilated, and central fixation was used. Parameters of the PERG stimulation were as follows: 21″ CRT monitor with a frame rate equal to 75 fps was used; black and white reversing checkerboard (30° FOV) was presented to the patient, with a check size equal to 1°2′; temporal frequency was equal to 4.6 rps (2.3 Hz), Michelson contrast: 97 %, luminance for white elements: 120 cd/m2. Electrodes: ground (gold disk) electrode was placed on the forehead (Fpz), thread DTL electrode was used as active, gold disk was placed at the outer, and canthus ipsilateral was used as reference. Parameters of the recording system were as follows: amplifiers sensitivity −20 µV/div, filters: 1–100 Hz, artifact reject threshold –95 % (for the amplifiers range ±100 µV), notch filters were off, averaging: 200 sweeps, sweep time: 250 ms (time base: 25 ms/div). Two consecutive waveforms were recorded; then, they were off-line averaged and analyzed. The PERG test parameters were in accordance with the ISCEV standard [22].

Pattern visual evoked potentials (PVEP)

Pupils were undilated. Stimulation was monocular. Eyes were refracted for the stimulus viewing distance (one meter). Parameters of the stimulation were as follows: 21″ CRT monitor with a frame rate: 75 fps was used, black/white reversing checkerboard was presented to the patient with a check size: 1°4′ and 0°16′, Michelson contrast: 97 %, temporal frequency: 2 rev/s (1 Hz), luminance for the white elements: 120 cd/m2 (mean luminance: 55 cd/m2). Electrodes: active-gold disk electrode was placed on the scalp over the visual cortex at Oz with reference-gold disk electrode placed at Fz; ground (gold disk) electrode was placed on the forehead at fpz. The electrodes were placed relatively to bone landmarks according to the international 10/20 system. Central fixation was carried out. Parameters of the recording system were as follows: filters: 1–100 Hz, notch filters were switched off, artifact reject threshold: 50 µV, sweep time: 300 ms, averaging: 100 sweeps. Two consecutive waveforms were recorded; then, they were averaged off-line and analyzed. The amplitude and time of the P100-wave with manual correction to the automatic cursor placement were also parsed. In order to evaluate the bioelectrical function of macular versus more peripheral regions of the retina stimulation with the small (0°16′) and large (1°4′), check stimuli were measured. The PVEP test parameters were in accordance with the ISCEV standard [23].

Cardiac ablation

The goal of AF ablation is to make an electrical isolation between the pulmonary veins-PV (which are the most common site of AF triggers) and the left cardiac atrium. The device used in this procedure was a Medtronic ArcticFront Adv. cryoballoon introduced through a femoral vein inside the left cardiac atrium by a transseptal approach. After inflating the cryoballoon, the device was placed consecutively in the ostium of each pulmonary vein. To reach low temperatures, a firm adhesion of the balloon to the PV is obligatory, which what is confirmed by injecting the contrast inside the balloon closed PV. No contrast leakage to the atrium confirms the proper placement of balloon (observed in fluoroscopy); the balloon is filled by a Medtronic Cryoconsole device with nitrous oxide which is providing low temperatures (often below –50 °C) on the balloon surface. The electrical conduction block was checked with a ten-pole lasso electrode placed inside each vein. During the whole procedure, each patient was heparinized by monitoring of the anticoagulation time (ACT) and adjusting the heparin dose targeting by 250–350 s.
In 12 eyes of the patients, additional ERG/PERG/PVEP examinations were performed after successful ablation. The mean follow-up period was 89 days (62–115 days), and during the follow-up there were no significant modifications of drugs among patients. Decrease in the group size (n = 32 to n = 12) resulted from the ineffectiveness of the ablation procedure, poor general condition of patients or lack of cooperation during the test.

Statistics

The Shapiro–Wilk test was used to evaluate the compatibility with normal distribution of analyzed electrophysiological parameters. The ERG/PERG/PVEP parameters in eyes of patients with AF and eyes of the control group were compared in the following way: (1) For normally distributed data, the arithmetic mean and standard deviation were applied, and Student’s t test was used (2) for non-normally distributed data, the Wilcoxon signed-rank test was used. The results were considered as normal when they included between mean and ±2SD (x ± 2SD) (normally distributed data) or between 2.5 and 97.5 percentiles (non-normally distributed data). Two parameters (amplitude and implicit time of waves) in following groups were analyzed:
1.
AF patients before ablation versus control group,
 
2.
AF patients before ablation versus AF patients after ablation.
 
Four hypotheses were tested; there was post hoc adjustment of p values for multiple testing (Bonferroni correction). The significance level was p < 0.0125 (0.05/4), and for statistical calculations, the number of eyes tested was used, rather than the number of subjects.

Results

Results of the statistical analyses (ERG) of AF patients in comparison with controls are shown in Table 1 and Figs. 1 and 2. Thirty-two eyes of 17 patients with AF (12 women and 20 men) were analyzed; the mean age was 63.2 years ± 7.8 (range of age 53–83 years). Eleven patients (n = 22 eyes) had treated arterial hypertension, and eight (n = 16 eyes) were smokers. No other systemic diseases were observed. The best-corrected visual acuity was 0.71 ± 2.2 (Snellen chart).
Table 1
Full-field electroretinogram—eyes of patients with AF (n = 32) in comparison with controls (n = 30)
 
Amplitude (µV)
Peak time (ms)
AF
N
Controls
N
p value
AF
N
Controls
N
p value
Rod b-wave
140.9 ± 79.1
+
160.0 ± 48.2
+
0.011
123.2 ± 16.1
+
110.1 ± 5.1
+
NS
Rod-cone a-wave
169.8 ± 45.2
+
191.5 ± 57.3
+
0.009
23.5 ± 3.4
+
23.7 ± 2.4
+
NS
Rod-cone b-wave
391.0 ± 64.1
+
429.8 ± 92.4
+
NS
48.5 ± 2.2
+
47.4 ± 3.0
+
NS
OPs wave index
67.4 ± 15.6
+
83.4 ± 39.0
+
0.012
     
Cone a-wave single flash
23.1 ± 4.4
+
25.7 ± 6.3
+
NS
14.4 ± 1.1
+
13.2 ± 0.9
+
NS
Cone b-wave single flash
73.4 ± 21.8
+
96.3 ± 29.5
+
0.008
28.2 ± 2.2
+
29.2 ± 1.5
+
NS
Cone 30-Hz flicker
50.6 ± 10.7
+
69.8 ± 24.1
+
0.009
31.5 ± 4.7
+
28.0 ± 2.3
+
0.005
Normally distributed data: values are mean ± SD
NS not significant (p > 0.0125), N normal distribution
In the ERG, a statistically significant reductions of amplitudes of waves in patients with AF were revealed; scotopic b-wave 24 dB (Ab = 140.9 vs. 160 μV; p = 0.011), scotopic a-wave 0 dB (Aa = 169.8 vs. 191.5 μV; p = 0009), photopic single flash b-wave (Ab = 73.4 vs. 96.3 μV; p = 0.008), photopic flicker response (Ab = 50.6 vs. 69.8 μV; p = 0.009), OPs WI = 67.4 vs. 83.0 μV (p = 0.012). The increase in peak time of the photopic flicker b-wave (31.5 vs. 28 ms; p = 0.005) was observed. Other parameters of the PERG/PVEP/ERG were not statistically significant in comparison with the control group (PERG/PVEP data not shown). Patients with pathological records of the ERG/PERG/PVEP did not have more severe disease (AF) in comparison with ones with normal results.
Three months after the ablation procedure, complete electrophysiological tests (ERG/PERG/PVEP) were performed (n = 12 eyes, six men, six women). The mean age was 65.4 years old ± 6.0 (range of age 53–72 years). Four patients (n = 8 eyes) had treated arterial hypertension; one (n = 2 eyes) was a smoker. No other systemic diseases were observed. Best-corrected visual acuity was 0.79 ± 1.4.
The only statistically significant change was an increase in the OPs WI: 97.6 versus 68.3 μV (p = 0.002; Fig. 2). Other ERG (Fig. 3; Table 2), PERG and PVEP (data not shown) parameters revealed no statistically significant changes. It has not been shown that patients with initially pathological ERG/PERG/PVEP records were exposed to greater risk of vision loss (p > 0.0125). Before ablation, the pathologic OPs WI were found in 24/32 eyes (75 %) (<−2SD for control group). After the treatment, the OPs WI increase to the normal values (−2SD < x < 2SD) in 14/24 (58 %) of the previous abnormal recordings were achieved. A greater response was observed in case of younger patients: under 65 years old 10/13 (76 %), in comparison with older ones–4/11 (36 %) after 65 years old.
Table 2
Full-field electroretinogram—eyes of patients with AF before and after ablation (n = 12)
 
Amplitude (µV)
p value
Peak time (ms)
p value
AF ablation
AF ablation
Before
N
After
N
Before
N
After
N
Rod b-wave
133.3 ± 101.7
+
146.6 ± 115.2
+
NS
130.6 ± 18.1
+
118.1 ± 17.8
+
NS
Rod-cone a-wave
182.5 ± 41.6
+
177.8 ± 55.3
+
NS
23.4 ± 2.2
23.9 (95 % CI 21.4–25.1
NS
Rod-cone b-wave
368.5 ± 69.1
+
371.4 ± 103.4
+
NS
46.6 ± 2.3
+
47.2 ± 2.4
+
NS
OPs wave index
68.4 ± 15.0
+
97.6 ± 14.4
+
0.002
     
Cone a-wave single flash
23.1 ± 3.9
+
23.7 ± 4.8
+
NS
14.2 ± 2.0
+
13.9 ± 1.5
+
NS
Cone b-wave single flash
68.7 (95 % CI 55.6–80.7)
77.2 ± 31.1
+
NS
29.3 ± 1.0
+
29.3 (95 % CI 27.7–31.0)
NS
Cone b-wave 30-Hz flicker
48.0 ± 12.3
+
50.2 ± 13.1
+
NS
33.6 ± 7.2
+
32.6 (95 % CI 29.2–35.9
NS
Normally distributed data: values are mean ± SD. Non-normally distributed data: values are mean (95 % confidence interval, 95 % CI)
NS not significant (p > 0.0125), N normal distribution

Discussion

The present study has shown the influence of cardiac arrhythmia on the electrophysiological function of the eyes.
In the ERG, a statistically significant reduction in the OPs WI, scotopic a-wave and photopic/scotopic (24 dB) b-wave amplitudes were revealed. The increase in peak time of the photopic flicker b-wave was observed as well. The reduction in the scotopic (0 dB) b-wave and photopic a-wave was present, but was not statistically significant. It is known from literature that a-wave is generated mainly from photoreceptors [24], and b-wave from bipolar cells [25, 26]. The oscillatory potentials (OPs) are small rhythmic waves superimposed on the ascending b-wave of the ERG, and the amacrine and bipolar cells are directly or indirectly involved in their generation [27]. Presented data suggest that dysfunction was present not only in the outer (photoreceptors), but also in the inner retina (bipolar/amacrine cells). This may indicate that the size of retinal dysfunction was greater than assumed. As mentioned in the introduction, the outer layers of the retina are more sensitive to ischemia, than the inner ones. The lowest level of oxygen [28] and pH [29] is reported at the level of the outer nuclear layer under scotopic conditions. It is associated with photoreceptors’ (mostly rods’) high energy/oxygen demands and specific circulation determinants. In the hypoxia, photoreceptors receive blood from the choroid-90 % and the retinal vessels-10 % (both dark and light adaptation) [12]. Although the choroid has one of the highest blood flows in the body, it has no effective autoregulation [16, 17]. In the contrast, retinal circulation (central retinal artery) is highly dependent of the blood concentration of O2, CO2 and pH levels in the inner retina [6, 16, 28]. A retinal flux can be increased in hypoxia by up to 336 % [6], which is not possible in the choroid. Moreover, as a response to the outer retina higher energy/oxygen consumption in the scotopic conditions, retinal flow may be increased by 40–70 % [29] and 67 % [30]. In comparison with the photopic conditions, in scotopic conditions photoreceptors oxygen consumption increases from 1.4 to 5.1 ml O2/100 g min [1113]. The inner layers of the retina consume oxygen at a constant level, regardless of the light conditions: 1.47–4.6 ml O2/100 g min [13, 3032]. This level is comparable to the oxygen consumption in the brain (2–5 ml O2/100 g min) [8]. The retinal dysfunction in AF patients occurred probably due to ischemia. Retinal ischemia usually affects the ERG peak latencies as well as the amplitudes. However, the rod-cone a-wave and cone b-wave amplitude reduction is not accompanied by an increase in peak time. This is probably due a large standard deviation of the patients’ responses with respect to controls (respectively, before ablation: cone a-wave SD 3.4 vs. 2.4 ms; cone b-wave SD 2.2 vs. 1.5 ms). Larger standard deviations were observed in the group of patients <65 years old. In the group >65 years old, the responses were more consistent and the amplitude reduction was accompanied by an increase in peak time. This may indicate a larger occurrence of ischemic changes in this group of patients. In the case of animal studies, it was found that the most sensitive indicator to ischemia was as follows: amplitude of b-wave [19, 3335], amplitude of the scotopic oscillatory potentials, photopic flicker response [3638], c-wave [19]. In human studies, scotopic OP amplitude [39, 40] and peak time [41] have been reported to be most affected by retinal ischemia. An ischemic etiology of electrophysiological abnormalities observed in patients with AF is supported by the fact that similar changes occur in other vascular diseases like hypertension [42, 43], diabetes mellitus [27] and carotid stenosis [27].
The function of retinal ganglion cells (RGC) in patients with AF was preserved. In the PERG test, no statistically significant changes in amplitudes and peak times of waves P50/N95 were found. These data are consistent with reports that the PERG factors are less susceptible to ischemia in comparison with the full-field ERG parameters [36]. In the PVEP tests in case of AF patients, no statistically significant results were obtained. However, a trend of an increase in P100-wave peak time after small check stimulation was observed (0°16′). There were no similar changes after the stimulation of large check (1°4′). The increased P100 peak time is not characteristic for optic nerve ischemia, contrary to reduced P100 amplitude [44, 45]. The optic nerve and RGC are both supplied with central retinal artery. It is suggested that high flux and good autoregulation mechanisms cause that these structures to be less susceptible to ischemia than the outer segments of the retina.
Influence of the cardiac arrhythmia treatment on the electrophysiological function of eyes has never been assessed. However, there have been numerous studies evaluating the positive effect of carotid stenosis treatment on the eye function [46]. An increased blood flow in the ocular vessels assessed in Doppler ultrasonography after such intervention is reported [46, 47]. It is possible that after AF ablation, similar mechanism at the level of retinal circulation may occur. After treatment, the trend of an increase in the amplitudes of P50 and N95 in the PERG test, the shortening of latency of P100 in the PVEP was observed. These results were not statistically significant, which may be due to the limited sample size (n = 12). In the full-field ERG, only the OPs WI has significantly improved after AF ablation (p = 0.002) (Fig. 3; Table 2). According to some authors, OPs are a good tool to detect early signs of circulatory disorders [48, 49]. However, a clear trend of scotopic/photopic b-wave amplitude increase of 10 and 12 %, respectively, was also observed. This may reflect the improvement of bipolar cell function. In the outer retina, the improvement was less evident (a-wave parameters). Better function of amacrine (validated) and bipolar cells (suggested) may confirm that the AF ablation may favorably affect the inner retina. Probably it is associated with a better blood supply and self-regulation of flows in the inner layers in comparison with the outer ones. That may explain, why effects of cardiac arrhythmia normalization can be seen more clearly in amacrine cells function, contrary to photoreceptors’ one, which was damaged both of them before and after ablation. It is worth noting that after the ablation procedure, only the OPs values were normalized (OPs VI = 97.6 µV after treatment vs. OPs VI = 83.4 µV controls). Other parameters, the a-wave and b-wave, despite the described improvement did not reach the level of the control group (“AF after treatment” Table 2 vs. “Controls” Table 1). In the authors’ opinion, this may indicate the existence of a persistent retinal hypoperfusion resulting from atherosclerotic changes. A cardiac cause of the hypoperfusion was excluded based on the normalization of heart rate and normal ejection fraction by ultrasound.
Before an ablation, the pathologic OPs WI was found in 75 % of eyes. After the treatment, normalization was observed in 76 % of eyes in patients under 65 years old, while only 36 % in case of above 65 years old. Presented OPs WI differences are probably caused by less advanced atherosclerosis among younger patients. It is suggested that this group is more likely to improve after the treatment. It seems reasonable that patients with persistent pathological OPs after ablation are at greater risk of vascular complications in the future, because of more advanced atherosclerosis. Therefore, this group of patients should undergo more careful and regular follow-ups, both cardiological and ophthalmological.

Conclusions

1.
In an analyzed series of AF patients’ retinal dysfunction was presented and detected in the ERG test.
 
2.
The AF ablation may improve a retinal function, which was registered on OPs WI.
 
3.
The OPs WI has a potential value in the estimation of the effectiveness of AF ablation.
 

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speaker’s bureaus; membership, employment, consultancies, stock ownership or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Fuster V, Rydén LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257–e354. doi:10.1161/CIRCULATIONAHA.106.177292 PubMedCrossRef Fuster V, Rydén LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114(7):e257–e354. doi:10.​1161/​CIRCULATIONAHA.​106.​177292 PubMedCrossRef
2.
Zurück zum Zitat Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375. doi:10.1001/jama.285.18.2370 PubMedCrossRef Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18):2370–2375. doi:10.​1001/​jama.​285.​18.​2370 PubMedCrossRef
4.
Zurück zum Zitat Gajewski P (2012) Choroby wewnętrzne. Medycyna Praktyczna, Kraków Gajewski P (2012) Choroby wewnętrzne. Medycyna Praktyczna, Kraków
6.
Zurück zum Zitat Ahmed J, Pulfer MK, Linsenmeier RA (2001) Measurement of blood flow through the retinal circulation of the cat during normoxia and hypoxemia using fluorescent microspheres. Microvasc Res 62(2):143–153PubMedCrossRef Ahmed J, Pulfer MK, Linsenmeier RA (2001) Measurement of blood flow through the retinal circulation of the cat during normoxia and hypoxemia using fluorescent microspheres. Microvasc Res 62(2):143–153PubMedCrossRef
7.
Zurück zum Zitat Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, Song JK, Park SW, Park SJ, Kim JJ (2006) Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 97(9):1365–1369PubMedCrossRef Choi BR, Kim JS, Yang YJ, Park KM, Lee CW, Kim YH, Hong MK, Song JK, Park SW, Park SJ, Kim JJ (2006) Factors associated with decreased cerebral blood flow in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 97(9):1365–1369PubMedCrossRef
8.
Zurück zum Zitat Purves MJ (1972) The physiology of the cerebral circulation. Monogr Physiol Soc. 28:1–414PubMed Purves MJ (1972) The physiology of the cerebral circulation. Monogr Physiol Soc. 28:1–414PubMed
10.
Zurück zum Zitat Schuchhardt S (1985) Myocardial oxygen pressure: mirror of oxygen supply. Adv Exp Med Biol 191:21–35PubMedCrossRef Schuchhardt S (1985) Myocardial oxygen pressure: mirror of oxygen supply. Adv Exp Med Biol 191:21–35PubMedCrossRef
11.
Zurück zum Zitat Haugh LM, Linsenmeier RA, Goldstick TK (1990) Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng 18(1):19–36PubMedCrossRef Haugh LM, Linsenmeier RA, Goldstick TK (1990) Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng 18(1):19–36PubMedCrossRef
12.
Zurück zum Zitat Linsenmeier RA, Braun RD (1992) Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol 99(2):177–197PubMedCrossRef Linsenmeier RA, Braun RD (1992) Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol 99(2):177–197PubMedCrossRef
13.
Zurück zum Zitat Braun RD, Linsenmeier RA, Goldstick TK (1995) Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci 36(3):542–554PubMed Braun RD, Linsenmeier RA, Goldstick TK (1995) Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci 36(3):542–554PubMed
14.
Zurück zum Zitat Zuckerman R, Weiter JJ (1980) Oxygen transport in the bullfrog retina. Exp Eye Res 30(2):117–127PubMedCrossRef Zuckerman R, Weiter JJ (1980) Oxygen transport in the bullfrog retina. Exp Eye Res 30(2):117–127PubMedCrossRef
15.
Zurück zum Zitat Ahmed J, Braun RD, Dunn R Jr, Linsenmeier RA (1993) Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 34(3):516–521PubMed Ahmed J, Braun RD, Dunn R Jr, Linsenmeier RA (1993) Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci 34(3):516–521PubMed
16.
17.
Zurück zum Zitat Friedman E, Chandra SR (1972) Choroidal blood flow. III. Effects of oxygen and carbon dioxide. Arch Ophthalmol 87(1):70–71PubMedCrossRef Friedman E, Chandra SR (1972) Choroidal blood flow. III. Effects of oxygen and carbon dioxide. Arch Ophthalmol 87(1):70–71PubMedCrossRef
18.
Zurück zum Zitat Linsenmeier RA (1990) Electrophysiological consequences of retinal hypoxia. Graefes Arch Clin Exp Ophthalmol 228(2):143–150PubMedCrossRef Linsenmeier RA (1990) Electrophysiological consequences of retinal hypoxia. Graefes Arch Clin Exp Ophthalmol 228(2):143–150PubMedCrossRef
19.
Zurück zum Zitat Linsenmeier RA, Mines AH, Steinberg RH (1983) Effects of hypoxia and hypercapnia on the light peak and electroretinogram of the cat. Invest Ophthalmol Vis Sci 24(1):37–46PubMed Linsenmeier RA, Mines AH, Steinberg RH (1983) Effects of hypoxia and hypercapnia on the light peak and electroretinogram of the cat. Invest Ophthalmol Vis Sci 24(1):37–46PubMed
21.
Zurück zum Zitat Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) Standard for clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77PubMedCrossRef Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) Standard for clinical electroretinography (2008 update). Doc Ophthalmol 118:69–77PubMedCrossRef
22.
Zurück zum Zitat Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M (2007) ISCEV standard for clinical pattern electroretinography—2007 update. Doc Ophthalmol 114:111–116PubMedCentralPubMedCrossRef Holder GE, Brigell MG, Hawlina M, Meigen T, Vaegan, Bach M (2007) ISCEV standard for clinical pattern electroretinography—2007 update. Doc Ophthalmol 114:111–116PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Odom JV, Bach M, Brigell M, Holder GH, McCulloch DL, Tormene AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials standard (2009 update). Doc Ophthalmol 120:111–119PubMedCrossRef Odom JV, Bach M, Brigell M, Holder GH, McCulloch DL, Tormene AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials standard (2009 update). Doc Ophthalmol 120:111–119PubMedCrossRef
24.
Zurück zum Zitat Palacz O, Lubiński W, Penkala K (2003) Elektrofizjologiczna diagnostyka kliniczna układu wzrokowego. Oftal, Warszawa Palacz O, Lubiński W, Penkala K (2003) Elektrofizjologiczna diagnostyka kliniczna układu wzrokowego. Oftal, Warszawa
25.
Zurück zum Zitat Karwowski CJ, Xu X (1999) Current source-density analysis of light-evoked field potentials in rabbit retina. Vis Neurosci 16(2):369–377 Karwowski CJ, Xu X (1999) Current source-density analysis of light-evoked field potentials in rabbit retina. Vis Neurosci 16(2):369–377
26.
Zurück zum Zitat Xu X, Karwowski CJ (1994) Current source density analysis of retinal field potentials. II. Pharmacological analysis of the b-wave and M-wave. J Neurophysiol 72(1):96–105PubMed Xu X, Karwowski CJ (1994) Current source density analysis of retinal field potentials. II. Pharmacological analysis of the b-wave and M-wave. J Neurophysiol 72(1):96–105PubMed
27.
Zurück zum Zitat Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17(4):485–521PubMedCrossRef Wachtmeister L (1998) Oscillatory potentials in the retina: what do they reveal. Prog Retin Eye Res 17(4):485–521PubMedCrossRef
28.
Zurück zum Zitat Linsenmeier RA (1986) Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 88(4):521–542PubMedCrossRef Linsenmeier RA (1986) Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol 88(4):521–542PubMedCrossRef
29.
Zurück zum Zitat Riva CE, Grunwald JE, Petrig BL (1983) Reactivity of the human retinal circulation to darkness: a laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 24(6):737–740PubMed Riva CE, Grunwald JE, Petrig BL (1983) Reactivity of the human retinal circulation to darkness: a laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 24(6):737–740PubMed
30.
Zurück zum Zitat Alm A, Bill A (1972) The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 84(3):306–319PubMedCrossRef Alm A, Bill A (1972) The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand 84(3):306–319PubMedCrossRef
31.
Zurück zum Zitat Alder VA, Ben-Nun J, Cringle SJ (1990) PO2 profiles and oxygen consumption in cat retina with an occluded retinal circulation. Invest Ophthalmol Vis Sci 31(6):1029–1034PubMed Alder VA, Ben-Nun J, Cringle SJ (1990) PO2 profiles and oxygen consumption in cat retina with an occluded retinal circulation. Invest Ophthalmol Vis Sci 31(6):1029–1034PubMed
32.
Zurück zum Zitat Törnquist P, Alm A (1979) Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand 106(3):351–357PubMedCrossRef Törnquist P, Alm A (1979) Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand 106(3):351–357PubMedCrossRef
33.
Zurück zum Zitat Osborne NN, Safa R, Nash MS (1999) Photoreceptors are preferentially affected in the rat retina following permanent occlusion of the carotid arteries. Vis Res 39:3995–4002PubMedCrossRef Osborne NN, Safa R, Nash MS (1999) Photoreceptors are preferentially affected in the rat retina following permanent occlusion of the carotid arteries. Vis Res 39:3995–4002PubMedCrossRef
34.
Zurück zum Zitat Block F, Schwarz M, Sontag KH (1992) Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci Lett 144(1–2):124–126PubMedCrossRef Block F, Schwarz M, Sontag KH (1992) Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci Lett 144(1–2):124–126PubMedCrossRef
35.
Zurück zum Zitat Barnett NL, Osborne NN (1995) Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp Eye Res 61:83–90PubMedCrossRef Barnett NL, Osborne NN (1995) Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp Eye Res 61:83–90PubMedCrossRef
36.
Zurück zum Zitat Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, Lagrèze WA (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci 49:1056–1064PubMedCrossRef Jehle T, Wingert K, Dimitriu C, Meschede W, Lasseck J, Bach M, Lagrèze WA (2008) Quantification of ischemic damage in the rat retina: a comparative study using evoked potentials, electroretinography, and histology. Invest Ophthalmol Vis Sci 49:1056–1064PubMedCrossRef
37.
Zurück zum Zitat Katano H, Ishihara M, Shiraishi Y, Kawai Y (2001) Effects of aging on the electroretinogram during ischemia-reperfusion in rats. Jpn J Physiol 51:89–97PubMedCrossRef Katano H, Ishihara M, Shiraishi Y, Kawai Y (2001) Effects of aging on the electroretinogram during ischemia-reperfusion in rats. Jpn J Physiol 51:89–97PubMedCrossRef
38.
Zurück zum Zitat Shibuki H, Katai N, Kuroiwa S et al (2002) Expression and neuroprotectiv effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 43:528–536PubMed Shibuki H, Katai N, Kuroiwa S et al (2002) Expression and neuroprotectiv effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 43:528–536PubMed
39.
Zurück zum Zitat Lovasik JV, Kergoat H (1991) Influence of transiently altered retinal vascular perfusion pressure on rod/cone contributions to scotopic oscillatory potentials. Ophthalmic Physiol Opt 11(4):370–380PubMedCrossRef Lovasik JV, Kergoat H (1991) Influence of transiently altered retinal vascular perfusion pressure on rod/cone contributions to scotopic oscillatory potentials. Ophthalmic Physiol Opt 11(4):370–380PubMedCrossRef
40.
Zurück zum Zitat Kergoat H, Lovasik JV (1990) The effects of altered retinal vascular perfusion pressure on the white flash scotopic ERG and oscillatory potentials in man. Electroencephalogr Clin Neurophysiol 75(4):306–322PubMedCrossRef Kergoat H, Lovasik JV (1990) The effects of altered retinal vascular perfusion pressure on the white flash scotopic ERG and oscillatory potentials in man. Electroencephalogr Clin Neurophysiol 75(4):306–322PubMedCrossRef
41.
Zurück zum Zitat Kothe AC, Lovasik JV, Coupland SG (1989) Variability in clinically measured photopic oscillatory potentials. Doc Ophthalmol 71(4):381–395PubMedCrossRef Kothe AC, Lovasik JV, Coupland SG (1989) Variability in clinically measured photopic oscillatory potentials. Doc Ophthalmol 71(4):381–395PubMedCrossRef
42.
Zurück zum Zitat Ravalico G, Rinaldi G, Solimano N, Bellini G, Cosenzi A, Sacerdote A, Bocin E (1995) Oscillatory potentials in subjects with treated hypertension. Ophthalmologica 209(4):187–189PubMedCrossRef Ravalico G, Rinaldi G, Solimano N, Bellini G, Cosenzi A, Sacerdote A, Bocin E (1995) Oscillatory potentials in subjects with treated hypertension. Ophthalmologica 209(4):187–189PubMedCrossRef
43.
Zurück zum Zitat Negretto AD, Rosa AA, Nakashima AA, Ortega KC, Mion Júnior D, Oyamada MK, Nakashima Y (2008) Evaluation of hypertensive retinopathy through the oscillatory potentials of the electroretinogram. Arq Bras Oftalmol 71(1):38–42PubMedCrossRef Negretto AD, Rosa AA, Nakashima AA, Ortega KC, Mion Júnior D, Oyamada MK, Nakashima Y (2008) Evaluation of hypertensive retinopathy through the oscillatory potentials of the electroretinogram. Arq Bras Oftalmol 71(1):38–42PubMedCrossRef
44.
Zurück zum Zitat Pojda-Wilczek D (2010) Retrospective analysis of pattern VEP results in different ocular and systemic diseases. Klin Oczna 112(7–9):205–209PubMed Pojda-Wilczek D (2010) Retrospective analysis of pattern VEP results in different ocular and systemic diseases. Klin Oczna 112(7–9):205–209PubMed
45.
Zurück zum Zitat Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye 18(11):1133–1143PubMedCrossRef Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye 18(11):1133–1143PubMedCrossRef
46.
Zurück zum Zitat Geroulakos G, Botchway LT, Pai V, Wilkinson AR, Galloway JM (1996) Effect of carotid endarterectomy on the ocular circulation and on ocular symptoms unrelated to emboli. Eur J Vasc Endovasc Surg 11(3):359–363PubMedCrossRef Geroulakos G, Botchway LT, Pai V, Wilkinson AR, Galloway JM (1996) Effect of carotid endarterectomy on the ocular circulation and on ocular symptoms unrelated to emboli. Eur J Vasc Endovasc Surg 11(3):359–363PubMedCrossRef
47.
Zurück zum Zitat Wang YL, Zhao L, Li MM (2011) Improved circulation in ocular ischemic syndrome after carotid artery stenting. Chin Med J 124(21):3598–3600PubMed Wang YL, Zhao L, Li MM (2011) Improved circulation in ocular ischemic syndrome after carotid artery stenting. Chin Med J 124(21):3598–3600PubMed
48.
Zurück zum Zitat Speros P, Price J (1981) Oscillatory potentials. History, techniques and potential use in the evaluation of disturbances of retinal circulation. Surv Ophthalmol 25(4):237–252PubMedCrossRef Speros P, Price J (1981) Oscillatory potentials. History, techniques and potential use in the evaluation of disturbances of retinal circulation. Surv Ophthalmol 25(4):237–252PubMedCrossRef
49.
Zurück zum Zitat Simonsen SE (1980) The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol 58(6):865–878CrossRef Simonsen SE (1980) The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol 58(6):865–878CrossRef
Metadaten
Titel
Electrophysiological function of the retina and optic nerve in patients with atrial fibrillation
verfasst von
Michal Post
Wojciech Goslawski
Monika Modrzejewska
Maciej Wielusinski
Jaroslaw Kazmierczak
Wojciech Lubinski
Publikationsdatum
01.08.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Documenta Ophthalmologica / Ausgabe 1/2015
Print ISSN: 0012-4486
Elektronische ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9498-6

Weitere Artikel der Ausgabe 1/2015

Documenta Ophthalmologica 1/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.